Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

What influences COVID-19 infection rates: A statistical approach to identify promising factors applied to infection data from Germany

Moritz Mercker, Uwe Betzin, Dennis Wilken
doi: https://doi.org/10.1101/2020.04.14.20064501
Moritz Mercker
1Bionum, Consultants in biological and biomedical statistics, Hamburg, Germany
2Institute of Applied Mathematics, Heidelberg University, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: info@bionum.de
Uwe Betzin
3User Experience Consultant, Schriesheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis Wilken
4Institute of Geosciences, Kiel University, Kiel, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The recent COVID-19 pandemic is of big and world-wide concern. There is an intense discussion and uncertainty which factors and sanctions can reduce infection rates. The overall aim is to prevent an overload of the medical system. Even within one country, there is frequently a strong local variability in both – political sanctions as well as other local factors – which may influence infection rates. The main focus of study is analysis and interpretation of recent temporal developments (infection rates). We present a statistical framework designed to identify local factors which reduce infection rates. The approach is robust with respect to the number of undetected infection cases. We apply the framework to spatio-temporal infection data from Germany. In particular, we demonstrate that (1) infection rates are in average significantly decreasing in Germany; (2) there is a high spatial variability of these rates, and (3) both, early emergence of first infections and high local infection densities has led to strong recent decays in infection rates, suggesting that psychological effects (such as awareness of danger) lead to behaviour changes that reduce infection rates. However, the full potential of the presented method cannot yet be exploited, since more precise spatio-temporal data, such as local cell phone-based mobility data, are not yet available. In the nearest future, the presented framework could be applied to data from other countries at any state of infection, even during the exponential phase of the growth of infection rates.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We did not receieve fundings for this study

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data evaluated in this study are publicly available

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 17, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
What influences COVID-19 infection rates: A statistical approach to identify promising factors applied to infection data from Germany
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
What influences COVID-19 infection rates: A statistical approach to identify promising factors applied to infection data from Germany
Moritz Mercker, Uwe Betzin, Dennis Wilken
medRxiv 2020.04.14.20064501; doi: https://doi.org/10.1101/2020.04.14.20064501
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
What influences COVID-19 infection rates: A statistical approach to identify promising factors applied to infection data from Germany
Moritz Mercker, Uwe Betzin, Dennis Wilken
medRxiv 2020.04.14.20064501; doi: https://doi.org/10.1101/2020.04.14.20064501

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1096)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (500)
  • Epidemiology (9767)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2308)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1559)
  • Health Policy (735)
  • Health Systems and Quality Improvement (603)
  • Hematology (236)
  • HIV/AIDS (503)
  • Infectious Diseases (except HIV/AIDS) (11641)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (237)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2142)
  • Nursing (134)
  • Nutrition (336)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (517)
  • Oncology (1176)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2180)
  • Public and Global Health (4657)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (251)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)